Amundi lifted its stake in shares of Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 89.4% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 5,047,699 shares of the real estate investment trust's stock after purchasing an additional 2,382,657 shares during the period. Amundi owned approximately 0.73% of Healthpeak Properties worth $98,228,000 at the end of the most recent quarter.
Several other hedge funds have also modified their holdings of the stock. Nuveen LLC acquired a new stake in Healthpeak Properties during the 1st quarter worth about $124,113,000. Resolution Capital Ltd purchased a new position in shares of Healthpeak Properties in the fourth quarter worth approximately $122,795,000. Invesco Ltd. raised its holdings in shares of Healthpeak Properties by 20.7% during the first quarter. Invesco Ltd. now owns 23,111,320 shares of the real estate investment trust's stock valued at $467,311,000 after acquiring an additional 3,967,830 shares during the period. Centersquare Investment Management LLC raised its holdings in shares of Healthpeak Properties by 18.5% during the first quarter. Centersquare Investment Management LLC now owns 13,285,932 shares of the real estate investment trust's stock valued at $268,642,000 after acquiring an additional 2,070,416 shares during the period. Finally, Universal Beteiligungs und Servicegesellschaft mbH acquired a new stake in shares of Healthpeak Properties during the fourth quarter valued at approximately $30,153,000. 93.57% of the stock is owned by hedge funds and other institutional investors.
Healthpeak Properties Stock Up 1.2%
Shares of NYSE DOC traded up $0.21 during mid-day trading on Thursday, reaching $18.16. The company had a trading volume of 6,798,537 shares, compared to its average volume of 6,048,133. Healthpeak Properties, Inc. has a twelve month low of $16.63 and a twelve month high of $23.26. The company has a debt-to-equity ratio of 1.06, a quick ratio of 1.28 and a current ratio of 1.28. The stock has a market capitalization of $12.62 billion, a PE ratio of 75.67, a price-to-earnings-growth ratio of 2.31 and a beta of 1.07. The stock's 50 day moving average is $17.76 and its 200-day moving average is $18.21.
Healthpeak Properties (NYSE:DOC - Get Free Report) last released its quarterly earnings data on Thursday, July 24th. The real estate investment trust reported $0.46 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $0.46. Healthpeak Properties had a return on equity of 1.85% and a net margin of 5.90%.The firm had revenue of $694.35 million during the quarter, compared to analysts' expectations of $697.14 million. During the same quarter last year, the firm earned $0.45 earnings per share. The business's revenue for the quarter was down .2% on a year-over-year basis. Healthpeak Properties has set its FY 2025 guidance at 1.810-1.870 EPS. As a group, equities analysts anticipate that Healthpeak Properties, Inc. will post 1.86 earnings per share for the current fiscal year.
Healthpeak Properties Dividend Announcement
The company also recently declared a monthly dividend, which was paid on Friday, August 29th. Stockholders of record on Monday, August 18th were issued a dividend of $0.1017 per share. This represents a c) annualized dividend and a dividend yield of 6.7%. The ex-dividend date was Monday, August 18th. Healthpeak Properties's payout ratio is currently 508.33%.
Wall Street Analysts Forecast Growth
DOC has been the subject of a number of recent analyst reports. Deutsche Bank Aktiengesellschaft reaffirmed a "hold" rating and issued a $18.00 price objective (down previously from $28.00) on shares of Healthpeak Properties in a research note on Wednesday, August 20th. Morgan Stanley reduced their target price on Healthpeak Properties from $22.00 to $21.00 and set an "overweight" rating for the company in a report on Friday, August 22nd. Wells Fargo & Company decreased their target price on Healthpeak Properties from $20.00 to $18.00 and set an "equal weight" rating for the company in a research report on Wednesday, August 27th. Scotiabank lowered Healthpeak Properties from a "sector outperform" rating to a "sector perform" rating and dropped their price target for the company from $21.00 to $19.00 in a research report on Tuesday, July 29th. Finally, Wall Street Zen downgraded Healthpeak Properties from a "hold" rating to a "sell" rating in a research note on Monday, July 7th. Seven equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average target price of $21.50.
Check Out Our Latest Stock Analysis on DOC
Insider Activity at Healthpeak Properties
In other news, CEO Scott M. Brinker acquired 1,490 shares of the company's stock in a transaction that occurred on Monday, August 4th. The shares were purchased at an average price of $16.83 per share, for a total transaction of $25,076.70. Following the completion of the acquisition, the chief executive officer owned 211,906 shares of the company's stock, valued at approximately $3,566,377.98. This represents a 0.71% increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Over the last three months, insiders purchased 8,783 shares of company stock valued at $150,129. Insiders own 0.23% of the company's stock.
About Healthpeak Properties
(
Free Report)
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
Featured Articles

Before you consider Healthpeak Properties, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthpeak Properties wasn't on the list.
While Healthpeak Properties currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.